Casula Manuela

Fixed-term Research Fellow A
SSD
BIO/14 - PHARMACOLOGY
Competition sector
05/G1 - PHARMACOLOGY, CLINICAL PHARMACOLOGY AND PHARMACOGNOSY

Contacts

Workplace

Via Balzaretti, 9/11/13
20133 MILANO (MI)

University email address

Teaching

Research

Publications
  • Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials / M. Casula, E. Olmastroni, M. Gazzotti, F. Galimberti, A. Zambon, A.L. Catapano. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 160(2020 Oct).
  • Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study / V. Russo, V. Orlando, V.M. Monetti, F. Galimberti, M. Casula, E. Olmastroni, E. Tragni, E. Menditto. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 11(2020 May 05).
  • Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study / M. Casula, E. Olmastroni, F. Galimberti, E. Tragni, G. Corrao, L. Scotti, A.L. Catapano. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 301(2020 May), pp. 1-7.
  • Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies / E. Olmastroni, M.T. Boccalari, E. Tragni, F. Rea, L. Merlino, G. Corrao, A.L. Catapano, M. Casula. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 155(2020), pp. 104514.1-104514.8.
  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk / F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - 41:1(2020), pp. 111-188.